Felix Bachmann

2.2k total citations
60 papers, 1.7k citations indexed

About

Felix Bachmann is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Felix Bachmann has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 25 papers in Molecular Biology and 25 papers in Cell Biology. Recurrent topics in Felix Bachmann's work include Microtubule and mitosis dynamics (23 papers), Cancer Treatment and Pharmacology (14 papers) and Glioma Diagnosis and Treatment (12 papers). Felix Bachmann is often cited by papers focused on Microtubule and mitosis dynamics (23 papers), Cancer Treatment and Pharmacology (14 papers) and Glioma Diagnosis and Treatment (12 papers). Felix Bachmann collaborates with scholars based in Switzerland, United Kingdom and United States. Felix Bachmann's co-authors include Heidi A. Lane, Christoph Uherek, Roland H. Gisler, P. Hammel, Beat A. Imhof, Dominique Dunon, Luca Piali, Max M. Burger, Milos Savcic and J Hauert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Felix Bachmann

56 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felix Bachmann Switzerland 18 797 341 234 218 206 60 1.7k
Vitaly A. Polunovsky United States 25 1.7k 2.2× 306 0.9× 181 0.8× 335 1.5× 301 1.5× 41 2.4k
Kristina Rafidi United States 9 1.1k 1.4× 361 1.1× 189 0.8× 118 0.5× 478 2.3× 9 1.7k
Wilfred W. Raymond United States 21 803 1.0× 394 1.2× 89 0.4× 1.1k 5.2× 349 1.7× 37 2.2k
Thorsten Sadowski Germany 17 399 0.5× 341 1.0× 113 0.5× 166 0.8× 371 1.8× 33 1.2k
Ruth Lehr United States 14 1.2k 1.5× 325 1.0× 111 0.5× 490 2.2× 113 0.5× 20 1.8k
Rey-Chen Pong United States 22 1.4k 1.7× 682 2.0× 149 0.6× 181 0.8× 325 1.6× 36 2.1k
Tatiana B. Gasic United States 15 605 0.8× 591 1.7× 136 0.6× 234 1.1× 356 1.7× 21 1.9k
Sabine Cerny‐Reiterer Austria 29 808 1.0× 453 1.3× 82 0.4× 692 3.2× 164 0.8× 65 2.2k
Josette Badet France 22 896 1.1× 194 0.6× 123 0.5× 150 0.7× 213 1.0× 49 1.5k

Countries citing papers authored by Felix Bachmann

Since Specialization
Citations

This map shows the geographic impact of Felix Bachmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Bachmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Bachmann more than expected).

Fields of papers citing papers by Felix Bachmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Bachmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Bachmann. The network helps show where Felix Bachmann may publish in the future.

Co-authorship network of co-authors of Felix Bachmann

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Bachmann. A scholar is included among the top collaborators of Felix Bachmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Bachmann. Felix Bachmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forster, Nicole, Felix Bachmann, Paul M.J. McSheehy, et al.. (2024). Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination. Frontiers in Oncology. 14. 1447807–1447807. 1 indexed citations
2.
Bachmann, Felix, et al.. (2023). Enzymatic post-treatment of ozonation: laccase-mediated removal of the by-products of acetaminophen ozonation. Environmental Science and Pollution Research. 30(18). 53128–53139. 5 indexed citations
3.
Bachmann, Felix, et al.. (2023). Tree Stem Detection and Crown Delineation in a Structurally Diverse Deciduous Forest Combining Leaf-On and Leaf-Off UAV-SfM Data. Remote Sensing. 15(18). 4366–4366. 9 indexed citations
4.
McSheehy, Paul M.J., Nicole Forster, Felix Bachmann, et al.. (2022). The fibroblast growth factor receptor inhibitor, derazantinib, has strong efficacy in human gastric tumor models and synergizes with paclitaxel in vivo. Anti-Cancer Drugs. 34(4). 532–543. 7 indexed citations
5.
6.
McSheehy, Paul M.J., Jessica K.R. Boult, Simon P. Robinson, et al.. (2020). Derazantinib, an oral fibroblast growth factor receptor inhibitor, in phase-2 clinical development, shows anti-angiogenic activity in pre-clinical models. European Journal of Cancer. 138. S25–S26. 4 indexed citations
7.
Krol, Ilona, Francesc Castro-Giner, Martina Maurer, et al.. (2018). Detection of circulating tumour cell clusters in human glioblastoma. British Journal of Cancer. 119(4). 487–491. 102 indexed citations
8.
Sharma, Ashish, Angela Broggini‐Tenzer, Van Vuong, et al.. (2017). The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models. Radiotherapy and Oncology. 124(3). 433–438. 7 indexed citations
9.
Bergès, Raphaël, Aurélie Tchoghandjian, Stéphane Honoré, et al.. (2016). The Novel Tubulin-Binding Checkpoint Activator BAL101553 Inhibits EB1-Dependent Migration and Invasion and Promotes Differentiation of Glioblastoma Stem-like Cells. Molecular Cancer Therapeutics. 15(11). 2740–2749. 21 indexed citations
10.
Prota, A.E., Franck Danel, Felix Bachmann, et al.. (2014). The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization. Journal of Molecular Biology. 426(8). 1848–1860. 240 indexed citations
11.
Spilka, Rita, Christina Ernst, Helmut Bergler, et al.. (2014). eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation. Cellular Oncology. 37(4). 253–267. 43 indexed citations
12.
Theurl, Igor, Heinz Zoller, Peter Obrist, et al.. (2004). Iron Regulates Hepatitis C Virus Translation via Stimulation of Expression of Translation Initiation Factor 3. The Journal of Infectious Diseases. 190(4). 819–825. 53 indexed citations
13.
Buechner, Stanislaw A., Marion Wernli, Felix Bachmann, Thomas Harr, & Peter Erb. (2002). Intralesional Interferon in Basal Cell Carcinoma: How Does It Work?. Recent results in cancer research. 160. 246–250. 10 indexed citations
14.
Mild, Gabriele, Felix Bachmann, Jean‐Louis Boulay, et al.. (2002). DCR3 locus is a predictive marker for 5‐fluorouracil‐based adjuvant chemotherapy in colorectal cancer. International Journal of Cancer. 102(3). 254–257. 31 indexed citations
15.
16.
Bachmann, Felix, et al.. (2001). Ultraviolet Light Downregulates CD95 Ligand and Trail Receptor Expression Facilitating Actinic Keratosis and Squamous Cell Carcinoma Formation. Journal of Investigative Dermatology. 117(1). 59–66. 54 indexed citations
17.
Harr, Thomas, et al.. (2001). Green fluorescent protein as a novel tool to measure apoptosis and necrosis. Cytometry. 43(2). 126–133. 53 indexed citations
18.
Ensinger, Christian, Peter Obrist, G. Mikuz, et al.. (1998). Assignment<footref rid="foot01"><sup>1</sup></footref> of the p150 subunit of the eukaryotic initiation factor 3A gene (EIF3A) to human chromosome band 10q26 by in situ hybridisation. Cytogenetic and Genome Research. 83(1-2). 74–75. 4 indexed citations
19.
Dellas, Athanassios, et al.. (1998). Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer. 83(7). 1376–1383. 70 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vitaly A. Polunovsky Breakdown of academic impact, for papers by Kristina Rafidi Breakdown of academic impact, for papers by Wilfred W. Raymond Breakdown of academic impact, for papers by Thorsten Sadowski Breakdown of academic impact, for papers by Ruth Lehr Breakdown of academic impact, for papers by Rey-Chen Pong Breakdown of academic impact, for papers by Tatiana B. Gasic Breakdown of academic impact, for papers by Sabine Cerny‐Reiterer Breakdown of academic impact, for papers by Josette Badet
Rankless by CCL
2026